[Serum protein studies on leukemic patients by the simple radial immunodiffusion method]

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

ESMO open·2025

Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial).

Cancer immunology, immunotherapy : CII·2025

Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial.

ESMO open·2025

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.

ESMO open·2022

Measurement of production with the hadronically decaying boson reconstructed as one or two jets in pp collisions at with ATLAS, and constraints on anomalous gauge couplings.

The European physical journal. C, Particles and fields·2020

Response to Comment on: "Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential".

Haematologica·2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Haematologica·2026

Response to Comment on: "SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia".

Haematologica·2026

Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.

Haematologica·2026

ATRA resistance conferred by a clustered subset of hotspot PML::RARA mutations enhancing basal repression rather than precluding transactivation.

Haematologica·2026

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Haematologica·2026

Prognostic Significance of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios for Complications of Diabetic Foot Ulcers: A Meta-Analysis.

Cureus·2026

The Metabolic Legacy of Acute Pancreatitis: Post-Pancreatitis Diabetes Mellitus.

Clinical and experimental gastroenterology·2026

Combining MRI dual-sequence radiomics and clinical parameters predicts post-hypertriglyceridemic acute pancreatitis diabetes mellitus.

Frontiers in endocrinology·2026

Integrative Proteomics-Metabolomics Profiling of Umbilical Cord Plasma With Machine Learning Reveals Candidate Biomarkers for Gestational Diabetes Mellitus.

Diabetes, obesity & metabolism·2026

Disease-mutations perturb proton transfer reactions in respiratory complex I.

Biochimica et biophysica acta. Bioenergetics·2026

Proteomic and lipidomic comparisons of milk fat globule membrane (MFGM) enriched ingredients from caprine and bovine buttermilk.

Food chemistry·2026

Related Experiment Videos

[Serum protein studies on leukemic patients by the simple radial immunodiffusion method]

Related Concept Videos

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial).

Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial.

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy.

Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.

Measurement of production with the hadronically decaying boson reconstructed as one or two jets in pp collisions at with ATLAS, and constraints on anomalous gauge couplings.

Response to Comment on: "Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential".

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Response to Comment on: "SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia".

Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.

ATRA resistance conferred by a clustered subset of hotspot PML::RARA mutations enhancing basal repression rather than precluding transactivation.

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Prognostic Significance of Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios for Complications of Diabetic Foot Ulcers: A Meta-Analysis.

The Metabolic Legacy of Acute Pancreatitis: Post-Pancreatitis Diabetes Mellitus.

Combining MRI dual-sequence radiomics and clinical parameters predicts post-hypertriglyceridemic acute pancreatitis diabetes mellitus.

Integrative Proteomics-Metabolomics Profiling of Umbilical Cord Plasma With Machine Learning Reveals Candidate Biomarkers for Gestational Diabetes Mellitus.

Disease-mutations perturb proton transfer reactions in respiratory complex I.

Proteomic and lipidomic comparisons of milk fat globule membrane (MFGM) enriched ingredients from caprine and bovine buttermilk.

Related Experiment Videos

[Serum protein studies on leukemic patients by the simple radial immunodiffusion method]

Related Concept Videos

Related Articles